Publications

Pre-clinical development of AP4B1 gene replacement therapy for hereditary spastic paraplegia type 47

 99
Pre-clinical development of AP4B1 gene replacement therapy for hereditary spastic paraplegia type 47

Tags:

Previous Article

Opposing roles for AMPK in regulating distinct mitophagy pathways

Next Article

Gene replacement therapy for hereditary spastic paraplegia type 47

Related Posts

Visual hallucinations in Parkinson's disease: spotlight on central cholinergic dysfunction

Visual hallucinations in Parkinson's disease: spotlight...

 100

Molecular mimicry as a driver of T cell-mediated tumour immunity

Molecular mimicry as a driver of T cell-mediated tumour...

 73

Condensate interfacial forces reposition DNA loci and probe chromatin viscoelasticity

Condensate interfacial forces reposition DNA loci and p...

 114